Open access
Sep 2026
Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation
Thrombotic and bleeding events were common in this real-world cohort of patients with cancer and AF receiving apixaban, highlighting the complexity of anticoagulation management in this high-risk population and support the need for close clinical monitoring and further prospective studies.
Lolwa Alabdelmuhsin, Metab F. Alwethairi, D. Alharbi et al.
· Frontiers in Cardiovascular... · 0 citations